Short Interest in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Decreases By 93.6%

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large drop in short interest in January. As of January 30th, there was short interest totaling 8,067 shares, a drop of 93.6% from the January 15th total of 126,819 shares. Based on an average daily volume of 392,314 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 392,314 shares, the days-to-cover ratio is currently 0.0 days.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ traded down $0.07 during mid-day trading on Wednesday, reaching $15.00. 97,938 shares of the company’s stock were exchanged, compared to its average volume of 334,722. The company’s 50-day moving average is $15.26 and its 200-day moving average is $14.81. BlackRock Health Sciences Term Trust has a 52-week low of $12.58 and a 52-week high of $16.20.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be given a dividend of $0.11 per share. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.8%.

Insider Activity

In related news, Director Robert W. Fairbairn sold 10,294 shares of the stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total value of $154,204.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds have recently made changes to their positions in the stock. Geneos Wealth Management Inc. acquired a new position in BlackRock Health Sciences Term Trust during the first quarter worth $40,000. Allworth Financial LP lifted its stake in BlackRock Health Sciences Term Trust by 24,584.6% during the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after acquiring an additional 3,196 shares in the last quarter. CWM LLC lifted its stake in BlackRock Health Sciences Term Trust by 25.6% during the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock worth $50,000 after acquiring an additional 680 shares in the last quarter. Newbridge Financial Services Group Inc. purchased a new position in BlackRock Health Sciences Term Trust during the 2nd quarter valued at about $69,000. Finally, Smartleaf Asset Management LLC acquired a new position in BlackRock Health Sciences Term Trust in the 3rd quarter valued at about $91,000.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.